As at May 8, 2025, the MEDP stock has a price-to-earnings ratio of 22.27. This is based on the current EPS of $13.51 and the stock price of $300.81 per share. A decrease of 22% has been recorded in the PE ratio compared to the average of 28.4 of the last four quarters.
The mean historical PE ratio of Medpace Holdings over the last nine years is 40.51. The current 22.27 P/E ratio is 45% lower than the historical average. In the past nine years, MEDP's PE ratio peaked in the Sep 2016 quarter at 248.83, with a price of $29.86 and an EPS of $0.12. The Mar 2025 quarter marked the lowest point at 22.55, with a price of $304.69 and an EPS of $13.51.
Maximum annual increase: 25.76% in 2021
Maximum annual decrease: -61.8% in 2017
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 25.44 | -23.65% | $332.23 | $13.06 |
2023 | 33.32 | 18.75% | $306.53 | $9.2 |
2022 | 28.06 | -34.76% | $212.41 | $7.57 |
2021 | 43.01 | 25.76% | $217.64 | $5.06 |
2020 | 34.2 | 13.51% | $139.2 | $4.07 |
2019 | 30.13 | 16.69% | $84.06 | $2.79 |
2018 | 25.82 | -28.79% | $52.93 | $2.05 |
2017 | 36.26 | -61.8% | $36.26 | $1 |
2016 | 94.92 | N/A | $36.07 | $0.38 |
2015 | N/A | N/A | N/A | -$0.28 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 22.55 | -11.36% | $304.69 | $13.51 |
Dec 2024 | 25.44 | -9.85% | $332.23 | $13.06 |
Sep 2024 | 28.22 | -24.48% | $333.8 | $11.83 |
Jun 2024 | 37.37 | -5.96% | $411.85 | $11.02 |
Mar 2024 | 39.74 | 19.27% | $404.15 | $10.17 |
Dec 2023 | 33.32 | 21.52% | $306.53 | $9.2 |
Sep 2023 | 27.42 | -1.12% | $242.13 | $8.83 |
Jun 2023 | 27.73 | 20.62% | $240.17 | $8.66 |
Mar 2023 | 22.99 | -18.07% | $188.05 | $8.18 |
Dec 2022 | 28.06 | 21.21% | $212.41 | $7.57 |
Sep 2022 | 23.15 | -7.03% | $157.17 | $6.79 |
Jun 2022 | 24.9 | -14.76% | $149.67 | $6.01 |
Mar 2022 | 29.21 | -32.09% | $163.59 | $5.6 |
Dec 2021 | 43.01 | 15.9% | $217.64 | $5.06 |
Sep 2021 | 37.11 | 3.17% | $189.28 | $5.1 |
The current PE ratio of MEDP is lower than the 3 and 5-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
MEDP Medpace Holdings Inc | 22.27 | $8.65B |
OLMA Olema Pharmaceuticals Inc | N/A | $319.12M |
OMER Omeros Corp | N/A | $366.38M |
VIVS VivoSim Labs Inc. | N/A | $2.88M |
ORIC Oric Pharmaceuticals Inc | N/A | $378.19M |
ORMP Oramed Pharmaceuticals Inc | N/A | $93.55M |
The price to earnings ratio for MEDP stock is 22.27 as of May 8, 2025.
As an average over the last 3 years, MEDP stock has a PE ratio of 28.41.
As an average over the last 5 years, MEDP stock has a PE ratio of 31.03.
The highest quarterly PE ratio in the last nine years has been 248.83 and it was in the Sep 2016 quarter.
MEDP's current price to earnings ratio is 45% below its 9-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (May 8, 2025), Medpace Holdings's stock price is $300.81. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $13.51. Therefore, Medpace Holdings's PE ratio for today is 22.27. PE RATIO(22.27) = STOCK PRICE($300.81) / TTM EPS($13.51)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.